WHO ICTRP trial
A Phase 1 Study to Evaluate the Potential Drug-Drug Interaction between GS-4224…
NL-OMON49788 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON49788 |
|---|---|
| Public title | A Phase 1 Study to Evaluate the Potential Drug-Drug Interaction between GS-4224 and Probe Inhibitors, Inducers and Substrates in Healthy Subjects |
| Scientific title | A Phase 1 Study to Evaluate the Potential Drug-Drug Interaction between GS-4224 and Probe Inhibitors, Inducers and Substrates in Healthy Subjects - GS-US-439-5302 DDI study in healthy subjects |
| Primary sponsor | Gilead Sciences, Inc. |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | The Netherlands |
| Conditions | Hepatitis B viral infection;10019654;Hepatitis B;viral infection |
| Interventions | See Protocol and ICF's. ;Chronic Hepatitis B;GS-4224 |
| Registration date | Dec 2, 2020 |
| Target size | 94 |
| Secondary IDs | 2019-003353-28;NL71694.056.19 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: